we get 520 proof of concept, sign a multi Billion $$$ partnership and the PPS will be heading for $100. But that scenario is 24/30 months down the road.
The stock can get into the $50's in the next 18 months on RNAi pipeline progess. alone.
very interesting .......... lots of support from the Hedge fund community
ARWR building a nice base in the low $7's
P2b 520 just around the corner = $8's PPS
When u have a clown analyst like tin-hoff with $80 TP's ,,,,,,,, longs only get Bent(_O_)ver the chair from his lack of understanding the biotech sector from a medical standpoint.
except that the nda has been moved out at least 2 years or more.
srpt will end up being a stock that patient traders will be able to buy for $8 on a general market pull back in 2014
we are all wating to sell under $13.50 ................ "NOT"
I sold a portion of my position at $13.90 and redeployed that cash into NBIX. They have a significant P2 VMAT2 trial do out in September for Tardive Dyskanisia and IMO the stock will trade towards $20
The buyer will most likely have their own MFG facilities. Are you telling me the likes of a Pfizer would subcontract the MFG of TED???????????
I will stand by my previous comments.